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Heart rate variability (HRV) decreases during hemorrhage, and has been proposed as a
new vital sign to assess cardiovascular stability in trauma patients. The purpose of this
study was to determine if any of the HRV metrics could accurately distinguish between
individuals with different tolerance to simulated hemorrhage. Speciﬁcally, we hypothesized
that (1) HRV would be similar in low tolerant (LT) and high tolerant (HT) subjects at pre-
syncope when both groups are on the verge of hemodynamic collapse; and (2) HRV could
distinguish LT subjects at presyncope from hemodynamically stable HT subjects (i.e., at a
submaximal level of hypovolemia). Lower body negative pressure (LBNP) was used as a
model of hemorrhage in healthy human subjects, eliciting central hypovolemia to the point
of presyncopal symptoms (onset of hemodynamic collapse). Subjects were classiﬁed as
LT if presyncopal symptoms occurred during the −15 to −60mmHg levels of LBNP, and HT
if symptoms occurred after LBNP of −60mmHg. A total of 20 HRV metrics were derived
from R–R interval measurements at the time of presyncope, and at one level prior to pre-
syncope (submax) in LT and HT groups. Only four HRV metrics (Long-range Detrended
Fluctuation Analysis, Forbidden Words, Poincaré Plot Descriptor Ratio, and Fractal Dimen-
sions byCurve Length) supported both hypotheses.These fourHRVmetricswere evaluated
further for their ability to identify individual LT subjects at presyncope when compared to
HT subjects at submax. Variability in individual LT and HT responses was so high that LT
responses overlapped with HT responses by 85–97%.The sensitivity of these HRV metrics
to distinguish between individual LT from HT subjects was 6–33%, and positive predictive
values were 40–73%.These results indicate that while a small number of HRV metrics can
accurately distinguish between LT and HT subjects using group mean data, individual HRV
values are poor indicators of tolerance to hypovolemia.
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INTRODUCTION
In trauma patients, the primary cause of death within the ﬁrst
hour of injury is hemorrhage (Bellamy, 1984; Sauaia et al., 1995;
Champion et al., 2003). Early detection of hypovolemia in trauma
patients is therefore critical to improving triage and providing
life saving interventions (LSIs). Unfortunately, the severity of
hemorrhage or central hypovolemia is difﬁcult to detect by ﬁrst
responders or other emergency medical personnel, as the tra-
ditional vital signs currently available to them, such as arterial
pressure, heart rate, respiration rate, and pulse character do not
consistently change until hemorrhage has progressed to the point
of decompensation (i.e., hemodynamic collapse; Heckbert et al.,
1998; Parks et al., 2006; Convertino et al., 2008). Assessing the
severity of hemorrhage in trauma patients is further complicated
by the reality that there are individuals who have a low tolerance
to hemorrhage such that, for the same level of blood loss, low tol-
erant (LT) individuals reach the point of cardiovascular collapse
in less time than those who are high tolerant (HT; Shoemaker
et al., 1973, 2006; Klemcke et al., 2011). Thus, there is an urgent
need to identify physiological parameters that can accurately track
hypovolemia in trauma patients, and have the sensitivity to pro-
vide early identiﬁcation of a patient that has a low tolerance to this
physiological insult. New vital signs are needed which can detect
the onset, progression, and severity of hypovolemia in individual
patients.
The measurement of the variation in R–R intervals, i.e., heart
rate variability (HRV; Malik, 1996), can provide information
regarding overall cardiovascular status. For instance, healthy indi-
viduals with normal autonomic function have high HRV, while
individuals with a stressed cardiovascular system (via activity, dis-
ease, or dysfunction) can be identiﬁed by reduced HRV (Thayer
and Sternberg, 2006).HRVhas been extensively studied in hospital
settings such as intensive care units to assess cardiovascular sta-
tus and predict mortality in trauma patients (Winchell and Hoyt,
1996, 1997; Grogan et al., 2005; Norris et al., 2005, 2008; Mor-
ris et al., 2006). Considering that monitoring electrocardiogram
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(ECG) signals is non-invasive, can be accomplished in all eche-
lons of care (including the pre-hospital environment), and can
potentially provide information regarding cardiovascular status,
the utility of HRV as a pre-hospital triage assist tool is the focus
of many investigations (Cooke et al., 2006a,b; Batchinsky et al.,
2007a; Cancio et al., 2008; Ryan et al., 2011).
One criterion for the development of accurate and timely
assessment of the clinical status of patients with hemorrhage is
the capability to investigate the continuous physiological response
to progressive reductions in central blood volume. This capability
has become available with the emergence of lower body negative
pressure (LBNP) as a human experimental model for hemorrhage
(Cooke et al., 2004). Cardiovascular responses during LBNP are
reproducible, and are consistent with those observed during hem-
orrhage (Convertino and Sather, 2000; Convertino, 2001; Cooke
et al., 2004). In addition, LBNP allows for the assessment of
cardiovascular responses which are speciﬁc to hypovolemia as
confounding factors associated with trauma such as pain and
inﬂammation are absent. Thus, the controlled experimental envi-
ronment of LBNP allows for optimal conditions in which to study
HRV. Using the LBNP model to induce a clinical endpoint (i.e.,
presyncope), human subjects can be identiﬁed as having HT or
LT to central hypovolemia (Sather et al., 1986; Convertino and
Sather, 2000; Rickards et al., 2011). If HRV metrics reﬂect the
status of cardiovascular stability during progressive central hypo-
volemia, then LT subjects would be expected to display greater
reductions in HRV compared to HT subjects. We therefore used
LBNP tolerance as a model to test the hypotheses that: (1) HRV at
presyncope is similar in LT and HT subjects when both groups are
on the verge of cardiovascular collapse, and (2) LT subjects have
lower HRV at presyncope compared to HT subjects who remain
hemodynamically stable.
MATERIALS AND METHODS
SUBJECTS
This studywas conducted under a protocol reviewed and approved
by the Brooke Army Medical Center and US Army Medical
Research and Materiel Command Institutional Review Boards and
in accordance with the approved protocol. All studies were con-
ducted at the U.S. Army Institute of Surgical Research, Fort Sam
Houston, TX, USA. Normotensive, non-smoking healthy human
volunteers (N = 120; male= 75, female= 45, age 28± 1 years;
height 174± 1 cm; weight 76± 1 kg) participated in this study
after evaluation of their medical history and physical examina-
tion by a physician to ensure the absence of previous and current
medical conditions that would exempt them as participants. All
female subjects were conﬁrmed as not pregnant by a urine preg-
nancy test conducted within an hour before the experiment. For
24 h prior to the study, participants were instructed to maintain
their normal sleep patterns, refrain from exercise, and abstain
from alcohol and autonomic stimulants including prescription
and non-prescription drugs such as caffeine, alcohol, and decon-
gestants. The potential effect of caffeine withdrawal on baseline
hemodynamics was not assessed in this study. Subjects were given
a written description of the experimental protocol and the risks
associated with the study. On the day of the study, the subjects
were made familiar with the laboratory, given a verbal brieﬁng on
the protocol and procedures, and encouraged to ask questions of
the investigators. All subjects signed an IRB approved informed
consent form.
LBNP PROTOCOL
Subjects were instrumented for standard lead II ECG to record
R–R intervals (RRI), and a ﬁnger cuff to record beat-by-beat ﬁn-
ger arterial pressure by photoplethysmography (Finometer Blood
Pressure Monitor, TNO-TPD Biomedical Instrumentation, Ams-
terdam, The Netherlands). To simulate hemorrhage in conscious
humans, central hypovolemiawas inducedby applicationof LBNP.
Previous studies have shown that the LBNP protocol can closely
simulate the hemodynamic challenges associated with pre-shock
hemorrhage (Cooke et al., 2004; Ward et al., 2010). Subjects were
positioned supine within an airtight chamber that was sealed at
the level of the iliac crest by a neoprene skirt. The LBNP protocol
consisted of a 5-min control period (baseline) followed by 5min
of chamber decompression at −15, −30, −45, and −60mmHg,
and then additional increments of −10mmHg every 5min until
the onset of cardiovascular collapse followed by a 10-min recovery
period. The application of LBNP was terminated based on three
criteria.: (a) sudden onset of relative bradycardia, (b) progres-
sive fall of systolic pressure below 80mmHg; and, (c) voluntary
subject termination due to the onset of presyncopal symptoms
such as sweating, nausea, dizziness, vision alterations, or general
discomfort. During the LBNP protocol, arterial pressure wave-
form (Finometer) and ECG signals were sampled continuously
at 500Hz and digitally recorded with WinDaq data acquisition
software (DATAQ Instruments, Akron, OH, USA).
HIGH TOLERANCE VS. LOW TOLERANCE
Subjects were categorized as LT or HT based on the level of LBNP
at which they experienced the onset of cardiovascular collapse
(Sather et al., 1986; Rickards et al., 2011). LT subjects experienced
cardiovascular collapse before or during −60mmHg of LBNP, and
HT subjects experienced cardiovascular collapse after −60mmHg
of LBNP.
DATA ANALYSIS
Arterial pressure waveform and ECG signals were analyzed during
the last 3min of each LBNP level using a commercially available
software program (WinCPRS, Absolute Aliens, Turku, Finland).
Beat-to-beat stroke volume was derived from the arterial pressure
waveform using the pulse contour method (Jansen et al., 1990).
Electrocardiogram signals were visually inspected and con-
ﬁrmed to be free of noise, persistent ectopic beats, or arrhythmias.
When ectopic beats were identiﬁed, the presence of a single event
within the 3-min analysis window resulted in the correction of
the beat by linear interpolation prior to analysis. If more than
one ectopic beat occurred during an LBNP level, the ECG data
for that level were not analyzed. Acceptable ECG signals were
used to calculate RRI and heart rate. The RRI signal was used
to derive 20 indices of HRV described in detail in previous pub-
lications from this laboratory (Rickards et al., 2010a; Ryan et al.,
2010). Linear methods were used to calculate HRV metrics in
both the time domain [n = 9; RRI standard deviation (RRISD),
RRI root mean squared standard deviation (RMSSD), percent-
age adjacent RRIs varying by at least 50ms (pNN50), Poincaré
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plot descriptors standard deviation 1 and standard deviation 2
(SD1 and SD2), SD1/SD2 ratio, SD2/SD1 ratio, complex demod-
ulation high frequency (CDM HF), complex demodulation-low
frequency (CDM LF)]; and frequency domain [n = 2; RRI low fre-
quency power (RRI LF), RRI high frequency power (RRI HF)].
For frequency domain analysis, the RRI signals were plotted using
linear interpolation, sampled at 5Hz, and then passed through a
low-pass impulse response ﬁlter with a cutoff frequency of 0.5Hz.
Data sets were submitted to a Fourier transform with a Hanning
window. Non-linear methods were used to calculate heart rate
complexity metrics from the RRI signal (n = 9; sample entropy
(SampEn), Lempel-Ziv entropy (LZEn), fractal dimensions by
curve length (FD-L), fractal dimensions by dispersion analysis
(FD-DA), symbol dynamics entropy (SymDyn), normalized sym-
bol dynamics entropy (DisnEn), long-range detrended ﬂuctuation
analysis (DFA long), short-range detrended ﬂuctuation analysis
(DFA short), and Forbidden Words (FW).
Heart rate variability metrics were compared in LT and HT
subjects at the level of LBNP at which cardiovascular collapse was
imminent (presyncope). In HT subjects, HRV metrics were also
calculated one level of LBNP prior to the presyncopal level (sub-
max), and compared with LT presyncopal values. HRV metrics
which measured equal variability in LT and HT at presyncope and
also less variability in LT at presyncope compared to HT at sub-
max were further evaluated for their ability to distinguish between
individual LT and HT subjects.
SENSITIVITY AND POSITIVE PREDICTIVE VALUE
The effectiveness of HRV metrics to accurately determine group
membership (HT or LT) was evaluated by calculating sensitivity
and positive predictive value. Sensitivity assesses the ability of a
HRV metric to correctly identify a LT subject from all the sub-
jects that were actually LT (i.e., true positives/true positives + false
negatives). Positive predictive value is a measure of the ability of
a HRV metric to identify a subject as LT from all the subjects that
“appear” to be LT (i.e., true positives/true positives+ false posi-
tives). A logistic regression model was used to evaluate the validity
of HRV metrics as predictors of low tolerance to hemorrhage.
Using this model, cutoff values were determined for each parame-
ter at each level of LBNP based on receiver-operator characteristic
analysis with speciﬁcity no less than 0.95. Sensitivity and posi-
tive predictive values were then calculated based on this criterion
(Pregibon, 1981).
STATISTICAL ANALYSIS
Data are expressed as mean± SE. Statistical analysis was con-
ducted with commercially available software (SigmaStat; Systat
Software, Richmond, CA, USA). Unpaired t -test, Chi-square, and
z-test analyses were used to compare subject demographics and
conditions at LBNP termination between tolerance groups. For
hemodynamic responses, a two way analysis of variance with
repeated measures on one variable was used to determine signiﬁ-
cant variable (tolerance and LBNP level) main effects (p ≤ 0.05).
Subsequent multiple comparison tests (Holm–Sidak) determined
signiﬁcant differences betweenHT and LT groups (p ≤ 0.05). HRV
measurements at presyncope and submax in LT and HT subjects
were compared by unpaired t -test.
RESULTS
SUBJECTS
The LBNP procedure was conducted on 120 subjects. LBNP was
terminated in 2 subjects during −30mmHg, in 5 subjects during
−45mmHg, in 26 subjects during −60mmHg, in 43 subjects dur-
ing −70mmHg, in 29 subjects during −80mmHg, in 13 subjects
during −90mmHg, and in 2 subjects during −100mmHg. As a
result, 33 subjects were identiﬁed as LT (27.5%) and 87 subjects
were identiﬁed as HT (72.5%). The demographics and baseline
mean arterial pressure and heart rates of these two groups of sub-
jects were not statistically different (Table 1). However, baseline
RRI was signiﬁcantly lower in LT subjects compared to HT sub-
jects. The presyncopal conditions observed at LBNP termination
are shown in Table 2. Cardiovascular conditions include systolic
pressure below 80mmHg and/or sudden onset of relative brady-
cardia, and presyncopal symptoms represent discomfort reported
by the subject. LT andHT subjects experienced similar presyncopal
conditions at LBNP termination.
RRI TRACKS HYPOVOLEMIA
Stroke volume and RRI at baseline (LBNP= 0mmHg) and dur-
ing LBNP in LT and HT subjects are shown in Figures 1A,B.
LT subjects experienced presyncopal conditions and/or symptoms
before or during LBNP level of −60mmHg. HT subjects experi-
enced presyncopal conditions and/or symptoms after−60mmHg.
Table 1 | Demographics and baseline hemodynamic variables for low
tolerant and high tolerant subjects.
Low tolerant High tolerant P value
N 33 87 <0.001
Male/female 18/15 57/30 0.37
Age (years) 27±1 29±1 0.32
Height (cm) 173±2 174±1 0.60
Weight (kg) 76±3 76±1 0.98
Mean arterial pressure (mmHg) 99±2 97±1 0.23
Heart rate (beats/min) 69±2 64±1 0.06
R–R interval (ms) 896±22 973±17 0.01
Data are expressed as mean±SE.
Table 2 | Prevalence of presyncopal conditions at LBNP termination in
low tolerant and high tolerant subjects.
Conditions at LBNP
termination
Low tolerant
(n=33)
High tolerant
(n=87)
P value
Cardiovascular+ symptoms 17 (52%) 51 (59%) 0.622
Cardiovascular only 5 (15%) 12 (14%) 0.917
Symptoms only 11 (33%) 24 (27%) 0.694
Cardiovascular conditions include systolic blood pressure below 80mmHg and/or
sudden bradycardia. Symptoms represent presyncopal symptoms such as sweat-
ing, nausea, dizziness, vision alterations, or general discomfort as reported by the
subject. Data are expressed as number of occurrences; group percentages are
shown in parentheses.
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FIGURE 1 | Stroke volume (A) and R–R interval (B) during progressive
lower body negative pressure (LBNP) in low tolerant subjects (closed
circles, solid line) and high tolerant subjects (open circles, dashed line).
At baseline, there are 33 low tolerant subjects and 87 high tolerant subjects.
The number of subjects at the subsequent time points during LBNP decline
as subjects experience presyncopal symptoms at various levels of LBNP. Data
are shown as mean±SE. ∗ Denotes group differences at the same LBNP
level (p ≤0.05).
Data for HT subjects are shown to LBNP level of −80mmHg.
Both stroke volume and RRI decreased in a similar incremen-
tal fashion during the progression of LBNP, and average RRI
measurements reﬂect and are correlated with the hypovolemia
induced by LBNP (amalgamated r2 = 0.988 between stroke vol-
ume and RRI). Stroke volume was not different between LT and
HT groups, but RRI was signiﬁcantly lower in LT subjects than
HT subjects at rest and during −15, −30, and −45mmHg LBNP
(p ≤ 0.01).
HRV MEASUREMENTS AT PRESYNCOPE AND SUBMAX LEVELS OF
LBNP
Figure 2 demonstrates the variation in RRI in a single LT sub-
ject and a single HT. These sample tracings of RRI were obtained
during LBNP level of −60mmHg, and are 3min in duration. The
variation in RRI is low in the LT subject who is on the verge of
cardiovascular collapse (at presyncope). In contrast, the variability
in RRI is high in the HT subject who is hemodynamically stable
(at submax).
Heart rate variability was quantiﬁed at presyncope in all LT
and HT subjects, and at submax in HT subjects by 20 HRV met-
rics. These results are shown in Table 3. The ﬁrst two columns
in Table 3 indicate the parameter or HRV metric and its pro-
portionality to variability. All HRV metrics are quantitatively
proportional (P) to HRV except SD2/SD1, DFA long, DFA short,
and FW, which are inversely proportional (I) to HRV. The val-
ues of proportional metrics decrease as variability decreases, while
the values of inversely proportional metrics increase as variabil-
ity decreases. Columns 3, 4, and 5 in Table 3 display the data
for three groups: LT at presyncope, HT at presyncope, and HT
at submax. The comparisons of variability between LT at presyn-
cope verses HT at presyncope, and LT at presyncope verses HT at
submax are also shown in Table 3, in columns 6 and 7, respec-
tively. The hypotheses of our study were (1) that at presyncope
HRV would be equal in LT and HT subjects (column 6) because
both groups are on the verge of cardiovascular collapse; and (2)
FIGURE 2 | Sample R–R interval tracings from one low tolerant subject
(lower tracing, open circles) and one high tolerant subject (upper
tracing, closed circles) are shown for a 2-min time span during LBNP
level of −60mmHg.
that LT subjects would have less HRV at presyncope compared
to HT subjects who remain hemodynamically stable at submax
(column 7). These hypotheses are stated in Table 3 above the
comparisons of HRV metrics (i.e., “LT=HT,”“LT<HT”). When
comparing HRV between groups it is important to keep in mind
that the numerical values of proportional metrics are consistent
with variability (i.e., high value indicates high variability), but
numerical values of metrics which are inversely proportional to
variability are opposite to variability (i.e., high value indicates low
variability). At presyncope, HRV was equivalent between LT and
HT groups as measured by 7 HRV metrics (bold type in column
6 of Table 3). When HRV was compared between LT subjects
at presyncope and HT subjects at submax, 8 metrics were less
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Table 3 | HR, RRI, and HRV metrics in LT at presyncope, HT at presyncope, and HT at submax.
Metric Proportional (P),
Inversely proportional (I)
LT at
presyncope
HT at
presyncope
HT at
submax
LT @ Presyncope vs.
HT@ Presyncope
LT @ Presyncope vs.
HT @ Submax
ECG SIGNAL
HR 97.3±3.0 117.9±2.3 106.3±2.1 LT<HT LT<HT
RRI 643.6±22.0 530.6±11.6 587.1±113.4 LT>HT LT>HT
HRV metrics Hypothesis Hypothesis
LT=HT LT<HT
TIME DOMAIN
RRISD P 64.1±6.0 38.9±2.3 36.7±1.9 LT>HT LT>HT
RMSSD P 23.9±5.8 9.6±0.9 14.8±1.2 LT>HT LT>HT
pNN50 P 3.2±1.1 0.9±0.2 2.5±0.6 LT>HT LT=HT
SD1 P 13.2±1.9 6.8±0.6 10.5±0.9 LT>HT LT=HT
SD2 P 88.2±8.1 54.0±3.2 50.1±2.6 LT>HT LT>HT
SD1/SD2* P 0.146±0.010 0.129±0.010 0.201±0.011 LT=HT LT<HT
SD2/SD1 I 7.80±0.50 10.17±0.53 5.85±0.24 LT>HT LT<HT
CDM HF P 12.8±1.7 6.9±0.6 11.7±1.1 LT>HT LT=HT
CDM LF P 27.1±2.3 20.1±1.7 27.9±1.9 LT>HT LT=HT
FREQUENCY DOMAIN
RRI HF P 216.1±88.7 55.6±10.6 188.9±38.1 LT>HT LT=HT
RRI LF P 432.7±91.4 302.4±62.3 742.7±111.4 LT=HT LT=HT
COMPLEXITY DOMAIN
SampEn P 0.707±0.048 0.57±0.029 0.821±0.031 LT>HT LT=HT
LZEn P 0.504±0.026 0.420±0.017 0.566±0.016 LT>HT LT<HT
FD-L* P 1.572±0.026 1.529±0.016 1.701±0.011 LT=HT LT<HT
FD-DA P 1.152±0.020 1.128±0.012 1.186±0.011 LT=HT LT=HT
SymDyn P 0.521±0.018 0.474±0.011 0.580±0.010 LT>HT LT<HT
DisnEn P 3.142±0.111 2.846±0.067 3.482±0.059 LT>HT LT<HT
DFA long* I 1.054±0.031 1.100±0.025 0.887±0.022 LT=HT LT<HT
DFA short I 1.564±0.052 1.619±0.034 1.605±0.029 LT=HT LT=HT
FW* I 67.3±0.9 69.1±0.7 63.8±0.7 LT=HT LT<HT
Data are shown in three groups: low tolerant (LT) at presyncope; high tolerant (HT) at presyncope; and HT at submax. Values (mean±SE) are shown for Heart Rate
(HR), R–R interval (RRI), RRI standard deviation (RRISD), RRI root mean squared standard deviation (RMSSD), percentage adjacent RRIs varying by at least 50ms
(pNN50), Poincaré plot descriptors standard deviation 1 (SD1), and standard deviation 2 (SD2), SD1/SD2 ratio, SD2/SD1 ratio, complex demodulation high frequency
(CDM HF), complex demodulation-low frequency (CDM LF), RRI high frequency power (HF), RRI low frequency power (LF), sample entropy (SampEn), Lempel-Ziv
entropy (LZEn), fractal dimensions by curve length (FD-L), fractal dimensions by dispersion analysis (FD-DA), symbol dynamics entropy (SymDyn), normalized symbol
dynamics entropy (DisnEn), long-range detrended ﬂuctuation analysis (DFA long), short-range detrended ﬂuctuation analysis (DFA short). P indicates HRV metrics
values proportional to RRI variability; I indicates HRV metrics values inversely proportional to RRI variability. Comparisons between groups are shown as LT=HT,
LT<HT, and LT>HT;<,> denote signiﬁcant difference between LT and HT group means (p≤0.05); bold type comparisons support the related hypothesis. ∗ Denotes
the metrics with responses to support both hypotheses.
variable in LT at presyncope (bold type in column 7 of Table 3).
The responses of DFA long, FW, SD1/SD2, and FD-L were the
only metrics to support both hypotheses, and are indicated by
an asterisk (∗) in Table 3. These four HRV metrics were further
evaluated for their ability to distinguish individual LT and HT
subjects.
DFA LONG, FW, SD1/SD2, AND FD-L IN INDIVIDUAL LT AND HT
SUBJECTS
DFA long, FW, SD1/SD2, and FD-L in individual LT subjects at
presyncope and individual HT subjects at submax are shown as
box and whisker plots in Figures 3A–D. Statistical analysis of
group averages (Table 3) reveal signiﬁcant differences in the four
HRV measurements between LT and HT groups. However, when
the measurements of DFA long, FW, SD1/SD2, and FD-L from
individual subjects are graphically displayed (Figures 3A–D), it
is evident that individual responses from LT subjects at presyn-
cope are predominantly within the range of responses observed in
HT subjects at submax despite the fact that LT subjects are on the
verge of cardiovascular collapse and HT subjects are hemodynam-
ically stable. The percentage of LT responses that were coincident
with HT responses were 97% for DFA long and FW, 94% for
SD1/SD2, and 85% for FD-L. The sensitivities of DFA long, FW,
SD1/SD2, and FD-L to identify individual LT subjects were low
(12, 6, 24, 33%), and positive predictive values were 50, 40, 67,
and 73%.
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FIGURE 3 | (A) Long-range detrended ﬂuctuation analysis (DFA
long), (B) forbidden words (FW), (C) Poincare plot standard
deviations ratio (SD1/SD2), and (D) fractal dimensions by curve
length (FD-L) in low tolerant (LT) at presyncope (solid circles,
n =33) and high tolerant (HT) at submax (open circles, n =87) level
of lower body negative pressure (LBNP). Data are shown as box
(25th/75th percentiles) and whisker (90th/10th percentiles) plots
with median value (black line).
DISCUSSION
To investigate the application of HRV monitoring for assessment
of hemodynamic stability during hemorrhage, we used an exper-
imental model to compare HRV metrics in LT and HT subjects
during LBNP. In order for any speciﬁc HRV metric to be con-
sidered as a valid candidate for the assessment of cardiovascular
stability in the context of central blood volume loss, two condi-
tions must hold true using this model: (1) LT and HT subjects
should display similar HRV at presyncope; and (2) HRV in LT
subjects should be less (i.e., LT subjects would be less stable) than
HRV in HT subjects at the point in time when LT subjects expe-
rienced presyncope. These conditions are based on the premise
that hemodynamic instability reﬂects a speciﬁc physiological con-
dition deﬁned by the inability of cardiovascular mechanisms to
adequately compensate for reduced central blood volume in all
subjects independent of their tolerance, and that LT subjects
are hemodynamically unstable at presyncope when HT subjects
remain stable. Our results indicate that of the 20 HRV metrics
evaluated, only four metrics (DFA Long, FW, SD1/SD2, and FD-L;
three of which were calculated by non-linear methods to assess
RRI irregularity or complexity) supported both hypotheses.
We propose that a metric which can predict low tolerance
in an individual subject prior to cardiovascular collapse would
be optimal for use as a triage assist tool. Identiﬁcation of LT
patients is particularly important as the ﬁrst responder will have
less time to initiate effective treatment in this patient population
compared with HT patients. Upon identifying the metrics which
supported our initial hypotheses, we further evaluated DFA Long,
FW, SD1/SD2, and FD-L on their utility as triage assist tools in
individual subjects. First, we compared the individual responses
from LT subjects at presyncope and HT subjects at submax to
determine the overlap in responses between the two groups. Sec-
ond, we assessed the accuracy of these HRV metrics in detecting
LT subjects at presyncope from the total subject pool (sensitivity
and positive predictive value).
While the group mean values of DFA Long, FW, SD1/SD2, and
FD-L (Table 3) distinguished between LT at presyncope (unstable)
and HT at submax (stable), the responses in individual LT and HT
subjects varied extensively such that 85–97% of the LT responses
overlappedwith those of HT subjects (Figures 3A–D). In addition,
the sensitivities of DFA Long, FW, SD1/SD2, and FD-L were 12, 6,
24, and 33%; while positive predictive values were 50, 40, 67, and
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73%. Considering that identifying LT subjects by chance alone has
50% sensitivity and 50% positive predictive value, the accuracy of
DFA Long and FW to identify LT subjects at presyncope was not
much better than ﬂipping a coin, or worse. Essentially, DFA Long
and FW did not adequately identify a LT individual even when the
subject was on the verge of cardiovascular collapse.
According to our results, FD-L had the highest positive predic-
tive value (73%), and thus had the highest potential for accurately
assessing hypovolemia of all 20 HRV metrics evaluated. How-
ever, the utility of FD-L to accurately monitor individual trauma
patientsmay be limited by potentially high variability in individual
responses. In the present study, under very controlled laboratory
conditions, the sensitivity of FD-L to identify a LT subject was only
33%, and the overlap of FD-L measurements from LT subjects and
HT subjects was 85% (Figure 3D). Overall, these results indicate
that the utility of FD-L as an accurate triage assisting tool for ﬁrst
responders is also limited.
Heart rate variability has been studied extensively during hem-
orrhage and trauma. HRV decreases with hypovolemia in human
LBNP studies (Cooke and Convertino, 2005; Cooke et al., 2008)
and in animal hemorrhage experiments (Batchinsky et al., 2007b,
2010). HRV has also been studied in pre-hospital environments
during transport of trauma patients. By retrospective analysis of
ECGdata fromactual traumapatients in transport to hospital care,
a number of investigators (Cooke et al., 2006a,b; Batchinsky et al.,
2007a; Cancio et al., 2008; Ong et al., 2008; King et al., 2009) have
identiﬁed several HRV metrics that are associated with mortality
or the need for a LSI. Importantly, however, all of these analy-
ses were based on evaluation of group mean data only, with no
consideration of the appropriateness of application to individual
patients.
Despite the observation of depressed HRV in subsets of trauma
patients, the use of HRV as a prognostic tool to assess the severity
of hemorrhage or trauma is controversial for a number of impor-
tant reasons. Ryan et al. (2010) evaluated the ability of numerous
HRV metrics to track hypovolemia in individual subjects under-
going simulated hemorrhagewith LBNP. They observed that when
group means were evaluated several metrics correlated very well
with reductions in stroke volume (r ≥ 0.87), but none of the HRV
metrics consistently correlated with changes in stroke volume in
individual subjects (r ≤ 0.49).
To further investigate the prognostic relevance of HRV,
Rickards et al. (2010b) evaluated a wide range of HRV metrics
and their association with the administration of LSIs in actual
trauma patients who all had normal vital signs during transport.
These patients would beneﬁt most from identiﬁcation of an early
predictor of cardiovascular collapse, as their physiological status
could not be accurately determined from currently available stan-
dard vital signs. Of the HRV metrics studied, only one metric,
FD-L, was uniquely associated with the administration of a LSI.
However, FD-L variance in both groups of patients was too high
to accurately determine group membership (LSI vs. No-LSI) on
an individual basis, and the number of false negatives identiﬁed
with FD-L further limited the power of this metric as an accurate
indicator of LSIs in individual trauma patients. Interestingly, FD-L
also showed the highest positive predictive value for identifying LT
subjects in the current study but, just as in trauma patients, the
overlap between individual responses from LT and HT subjects
was large (85%), and we found the sensitivity (33%) of this metric
to be limited.
There are several technical factors associated with ECG moni-
toring which can limit the usefulness of HRV metrics in a pre-
hospital setting. First, ECG signals must display normal sinus
rhythm for accurate calculation of HRV, but trauma patients often
develop arrhythmias such as premature atrial and ventricular con-
tractions (Sethuraman et al., 2010). Second, ECG signals must
have a low level of random noise, which usually results from
motion artifact, an unavoidable consequence of patient trans-
port in the pre-hospital setting. Third, the data from the ECG
signal should be stationary, i.e., a relatively stable RRI signal
withoutwideﬂuctuations from interventions or patientmanipula-
tion. Unfortunately, standard pre-hospital care typically requires
extensive patient interventions and manipulation. Other factors
which can also contribute to ECG non-stationarity such as dis-
ease, age, recreational drugs, medications, alcohol, smoking, and
postural changes are widely present in the trauma patient popu-
lation (Bilchick and Berger, 2006). Finally, the length of the ECG
data set required for accuratemeasurements varies byHRVmetric,
and can range from 100 to 800 RRIs; which can be an inordinately
long time in a trauma patient with rapidly changing physiolog-
ical status (Acharya et al., 2006; Rickards et al., 2010a). Thus,
the quality of HRV measurements are optimal when they can be
calculated from extended, stable ECG recordings under standard-
ized and very stable conditions; these conditions, however, are not
typically encountered when ﬁrst responders are treating trauma
patients.
Historically, heart rate has been closely monitored in trauma
patients because of the widely accepted notion that the magni-
tude of tachycardia reﬂects the degree of hypovolemia. However,
the reliability of tachycardia in response to hypovolemia has been
questioned as tachycardia can be absent in many trauma patients
despite the development of hypotension associated with bleeding
(Victorino et al., 2003; Brasel et al., 2007). In addition, the results
of the current study indicate that tachycardia was a poor indicator
of tolerance to hypovolemia because LT subjects at presyncope had
lower heart rates thanHT subjects at greater levels of central hypo-
volemia (Table 3). Based on the clinical doctrine that tachycardia
signals amore severe state of hypovolemia and the approach of car-
diovascular collapse, theHT subjects would have been erroneously
identiﬁed asmore hemodynamically unstable and at greater risk of
developing circulatory shock than LT subjects. Although a change
in cardiac rhythm may represent an adverse clinical status during
hemorrhage, the results of the present study reinforce the unreli-
ability of heart rate (and subsequently calculated metrics derived
from heart rate such as HRV) for patient triage.
In summary, the results of the current study are consistent with
the ﬁndings that ECG-derived metrics of HRV failed to provide
reliable information about clinical status in individual subjects
during progressive reductions in central blood volume similar to
those experienced during hemorrhage (Ryan et al., 2010), or the
need for LSIs in individual traumapatients (Rickards et al., 2010b).
In the present study,heart rate andHRVmetrics derived fromECG
signals were found to be poor indicators of LT to hypovolemia
even in the controlled experimental environment of simulated
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hemorrhage. This study raises further concern that monitoring
heart rate or calculated derivatives of heart rate (e.g., HRV) will
not reliably identify those patients who are least tolerant to hypo-
volemia and therefore at highest risk for early hemodynamic
collapse during hemorrhage.
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